Powered by Digital Intelligence, Advancing Together | Jincheng Pharma and Lan-bridge Open a New Chapter in Intelligent Pharmaceutical Translation

Advancing Together

On July 16, 2026, Shandong Jincheng Pharmaceutical Group Co., Ltd. and Lan-bridge held a project review and launch meeting for their AI translation platform.

Through this partnership, Lan-bridge will combine the LanTMS translation management platform with its life sciences language service capabilities to provide Jincheng Pharma with an enterprise-level AI translation solution. The platform covers professional document translation, terminology and translation memory management, online review, project collaboration, and data security, supporting multilingual content processing across international cooperation, professional research, and global business development.

Deep Roots in the Pharmaceutical Industry

Growing Global Translation Needs

Founded in 2004 and listed on the ChiNext Market of the Shenzhen Stock Exchange in 2011, Jincheng Pharma is one of China’s leading pharmaceutical companies.

The company has established nine modern production bases across major pharmaceutical industry clusters, including Shandong, Shanghai, Guangdong, Beijing, and Hebei. Its integrated production capabilities cover pharmaceutical preparations, chemical active pharmaceutical ingredients, biosynthetic active pharmaceutical ingredients, and pharmaceutical intermediates. Its cephalosporin intermediates and glutathione active pharmaceutical ingredients hold leading positions in the domestic market.

While strengthening its position in China, Jincheng Pharma continues to expand internationally and accelerate overseas registration and certification for its active pharmaceutical ingredients. The company has made progress in customer qualification, international registration, and European CEP certification.

As overseas registration and cross-border cooperation continue to develop, the volume of professional materials—including clinical registration dossiers, pharmaceutical patents, medical literature, non-clinical research documents, and clinical study reports—has continued to grow.

With an annual translation volume exceeding one million Chinese characters, Jincheng Pharma requires stronger terminology consistency, more efficient processing of complex documents, smoother cross-department collaboration, and more robust protection for sensitive business data.

A Strategic Partnership

Building a Dedicated AI Language Service System

Following a comprehensive evaluation of professional expertise, platform technology, and project delivery capabilities, Jincheng Pharma selected Lan-bridge as its partner and introduced the LanTMS translation management platform.

The two parties will develop a dedicated AI language service system for Jincheng Pharma, covering pharmaceutical document translation, terminology and translation memory management, online review, project collaboration, and data security.

By managing translation requests, historical translations, and professional terminology on a unified platform, Jincheng Pharma can gradually turn previously dispersed content into reusable corporate language assets. These assets will support international registration, professional research, and cross-border business collaboration.

AI in Practice

Supporting the Full Pharmaceutical Translation Workflow

The project has completed the deployment of core capabilities, including LanMT text translation, LanDocs document translation, LanCAT online editing, project management, terminology management, translation memory management, and bilingual corpus alignment.

The platform can combine LanMT with large language model translation engines to process professional pharmaceutical documents. It can also apply specialized language resources covering drug classification, manufacturing quality and compliance, regulatory submissions, clinical medicine, non-clinical research, toxicology, and pathology, helping improve translation accuracy and terminology consistency.

The project uses a hybrid deployment model. Core platform functions are deployed within Jincheng Pharma’s local environment, while access controls and operation logs provide additional protection for professional documents and corporate language assets.

LanCAT Online Editing

LanCAT provides translators and reviewers with a unified online editing environment. Users can view source text, translations, context, and relevant terminology in the same interface while completing translation editing, online review, and team collaboration.

Document Translation Preview

After professional documents are uploaded, users can configure translation settings, generate translations, preview results, and export translated files directly within LanTMS. This reduces repeated file splitting, content copying, and offline document transfers.

Professional Terminology Management

The platform supports centralized management of pharmaceutical terminology and allows approved terminology to be applied during text translation, document translation, and online review.

Confirmed terms and translations can also be continuously added to Jincheng Pharma’s dedicated terminology databases and translation memories, providing reusable professional language resources for future projects.

Long-Term Collaboration

Continuously Strengthening Global Language Capabilities

Following the platform launch, the two parties will continue with system training, trial operations, and customized feature development.

Further improvements will include large-file task segmentation, translation agents, AI assistants, and AI QA capabilities. Approved terminology and translation results will continue to be added to Jincheng Pharma’s dedicated terminology databases and translation memories, supporting medical research, international cooperation, and professional document processing.

This partnership represents another important application of Lan-bridge’s AI translation management capabilities in the life sciences sector.

Lan-bridge will continue to combine AI translation technology, pharmaceutical language resources, and professional service experience to provide Jincheng Pharma with long-term and reliable language technology support for its global registration strategy, research and development, and international business growth.